logo_black.png
EXMceuticals Inc. Announces Transformational Merger with Global Cannabinoids and Launches Concurrent Equity Financing
March 03, 2021 10:26 ET | EXMceuticals Inc.
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, March 03, 2021 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the "Company" or...
exm_logo.png
EXMceuticals Inc. Announces Receipt of Landmark COVID-19 Research Grant and Acceleration of Portuguese Activities
September 08, 2020 09:00 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, Sept. 08, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-sciences company specializing in the production...
exm_logo.png
EXMceuticals Inc. Announces Advancement of R&D Operations in Portugal and Efforts to Fight COVID-19 Pandemic
August 25, 2020 08:00 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging bio-science company specializing in the production of...
exm_logo.png
EXMceuticals Inc. Announces Shares for Debt Settlement
August 21, 2020 21:16 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, Aug. 21, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company”) announces that it has settled $1,378,241 of debt with creditors by issuing...
exm_logo.png
EXMceuticals Inc. Announces Loan Settlement and Share Issuance
July 28, 2020 16:39 ET | EXMceuticals Inc.
Not for distribution in the U.S. or to U.S. Newswire Services VANCOUVER, British Columbia, July 28, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the “Company” or “EXM”) is...
exm_logo.png
EXMceuticals Inc. Announces Closing of Oversubscribed Private Placement and Strategic Debt to Equity Conversion Strengthening the Corporation’s Balance Sheet
July 22, 2020 15:18 ET | EXMceuticals Inc.
Not for distribution in the U.S. or to U.S. Newswire Services VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM") is...
exm_logo.png
EXMceuticals Inc. Strengthens Positioning as a Gateway to the European Market through Supply Agreement for THC Distillate
June 11, 2020 09:00 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, June 11, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), is pleased to announce that it has entered into a letter of...
exm_logo.png
EXMceuticals Inc. Secures Supply & Offtake Agreements-In-Principle for Proposed Portugal Refinery
May 07, 2020 08:00 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2), (the "Company" or "EXM"), an emerging producer of refined cannabis ingredients serving the...
exm_logo.png
EXMceuticals Inc. provides an update on activities and announces a new Board Member and Corporate Secretary
March 03, 2020 09:17 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, March 03, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of cannabis extractions and refined ingredients for...
exm_logo.png
EXMceuticals Inc. appoints Michael Kinley as CFO
February 06, 2020 13:00 ET | EXMceuticals Inc.
VANCOUVER, British Columbia, Feb. 06, 2020 (GLOBE NEWSWIRE) -- EXMceuticals Inc. (CSE: EXM) (FSE: A2PAW2) (the “Company” or “EXM”), a producer of high-grade cannabis extracted ingredients for the...